Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nina Kerres"'
Autor:
Nina Kerres, Steffen Steurer, Stefanie Schlager, Gerd Bader, Helmut Berger, Maureen Caligiuri, Christian Dank, John R. Engen, Peter Ettmayer, Bernhard Fischerauer, Gerlinde Flotzinger, Daniel Gerlach, Thomas Gerstberger, Teresa Gmaschitz, Peter Greb, Bingsong Han, Elizabeth Heyes, Roxana E. Iacob, Dirk Kessler, Heike Kölle, Lyne Lamarre, David R. Lancia, Simon Lucas, Moriz Mayer, Katharina Mayr, Nikolai Mischerikow, Katja Mück, Christoph Peinsipp, Oliver Petermann, Ulrich Reiser, Dorothea Rudolph, Klaus Rumpel, Carina Salomon, Dirk Scharn, Renate Schnitzer, Andreas Schrenk, Norbert Schweifer, Diane Thompson, Elisabeth Traxler, Roland Varecka, Tilman Voss, Alexander Weiss-Puxbaum, Sandra Winkler, Xiaozhang Zheng, Andreas Zoephel, Norbert Kraut, Darryl McConnell, Mark Pearson, Manfred Koegl
Publikováno v:
Cell Reports, Vol 20, Iss 12, Pp 2860-2875 (2017)
The transcription factor BCL6 is a known driver of oncogenesis in lymphoid malignancies, including diffuse large B cell lymphoma (DLBCL). Disruption of its interaction with transcriptional repressors interferes with the oncogenic effects of BCL6. We
Externí odkaz:
https://doaj.org/article/43ac770ae3294c078849cf3143253f8a
Autor:
Elisabeth Grondal, Jale Karolyi-Oezguer, Dorothea Rudolph, Juergen Ramharter, Gerhard Gmaschitz, Geraldine Garavel, Joachim Broeker, Nina Kerres, Julian E. Fuchs, Patrick Werni, Karin S. Hofbauer, Wolfgang Hela, Andreas Gollner, Harald Weinstabl, Darryl B. McConnell
Publikováno v:
Chemmedchem
Mouse double minute 2 (MDM2) is a main and direct inhibitor of the crucial tumor suppressor p53. Reports from initial clinical trials showed that blocking this interaction with a small‐molecule inhibitor can have great value in the treatment of can
Autor:
David R. Lancia, John R. Engen, Elizabeth Heyes, Katharina Mayr, Lyne Lamarre, Mark Pearson, Carina Salomon, Simon Lucas, Steffen Steurer, Alexander Weiss-Puxbaum, Klaus Rumpel, Gerlinde Flotzinger, Norbert Kraut, Xiaozhang Zheng, Daniel Gerlach, Katja Mück, Sandra Winkler, Heike Kölle, Peter Ettmayer, Nikolai Mischerikow, Christian Dank, Ulrich Reiser, Dirk Scharn, Bingsong Han, Teresa Gmaschitz, Andreas Schrenk, Nina Kerres, Norbert Schweifer, Dirk Kessler, Tilman Voss, Renate Schnitzer, Manfred Koegl, Roland Varecka, Moriz Mayer, Dorothea Rudolph, Oliver Petermann, Diane Thompson, Thomas Gerstberger, Christoph Peinsipp, Roxana E. Iacob, Stefanie Schlager, Gerd Bader, Helmut Berger, Peter Greb, Maureen Caligiuri, Elisabeth Traxler, Bernhard Fischerauer, Andreas Zoephel, Darryl B. McConnell
Publikováno v:
Cell Reports, Vol 20, Iss 12, Pp 2860-2875 (2017)
Summary The transcription factor BCL6 is a known driver of oncogenesis in lymphoid malignancies, including diffuse large B cell lymphoma (DLBCL). Disruption of its interaction with transcriptional repressors interferes with the oncogenic effects of B
Autor:
Mark Pearson, David R. Lancia, Daniel Gerlach, John R. Engen, Andreas Zoephel, Darryl B. McConnell, Nina Kerres, Christian Dank, Xiaozhang Zheng, Stefanie Schlager, Gerd Bader, Tilman Voss, Nikolai Mischerikow, Renate Schnitzer, Norbert Kraut, Mayer Moriz, Thomas Gerstberger, Maureen Caligiuri, Manfred Koegl, Bingsong Han, Peter Ettmayer, Klaus Rumpel, Roxana E. Iacob, Dirk Kessler, Steffen Steurer
Publikováno v:
Cancer Research. 78:3354-3354
The transcription factor BCL6 is a known driver of oncogenesis in lymphoid malignancies, including diffuse large B-cell lymphoma (DLBCL). Disruption of its interaction with transcriptional repressors interferes with the oncogenic effects of BCL6. We
Autor:
Moriz Mayer, Simon Lucas, Peter Ettmayer, Stefanie Schlager, Nina Kerres, Zoephel Andreas, Norbert Kraut, Sophia M. Blake, Thomas Gerstberger, Manfred Koegl, John R. Engen, Steffen Steurer, Rumpel Klaus, Mischerikow Nikolai, Tilman Voss, Daniel Gerlach, Pearson Mark, Scharn Dirk, Schnitzer Renate, Darryl B. McConnell, Gerd Bader, Helmut Berger, Roxana Jacob, Maureen Caligiuri
Publikováno v:
Cancer Research. 77:1525-1525
The transcription factor BCL6 is a known driver of oncogenesis in lymphoid malignancies, including diffuse large B-cell lymphoma (DLBCL). It is a DNA-binding protein that represses gene transcription through the recruitment of co-repressor proteins v